List of SBIR/STTR awards granted to Gennext Technologies Ltd
Gennext Technologies LtdName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Gennext Technologies Ltd in April, 2019 for $1,134,434.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM125420-02 | Phase II | 1,134,434 | April 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Gennext Technologies Ltd in February, 2020 for $477,220.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM126617-02 | Phase II | 477,220 | February 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Gennext Technologies Ltd in April, 2018 for $224,931.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM128486-01 | Phase I | 224,931 | April 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Gennext Technologies Ltd in January, 2018 for $223,704.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM126617-01 | Phase I | 223,704 | January 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Gennext Technologies Ltd in April, 2020 for $261,509.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM137728-01 | Phase I | 261,509 | April 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Gennext Technologies Ltd in May, 2021 for $251,384.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM142351-01 | Phase I | 251,384 | May 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Gennext Technologies Ltd in April, 2021 for $480,459.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM131533-02 | Phase II | 480,459 | April 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Gennext Technologies Ltd in March, 2022 for $1,334,584.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM137728-02 | Phase II | 1,334,584 | March 9, 2022 | |||||||
A STTR Phase I contract was awarded to Gennext Technologies Ltd in January, 2019 for $225,285.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41GM131533-01 | Phase I | 225,285 | January 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Gennext Technologies Ltd in September, 2017 for $224,995.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM125420-01 | Phase I | 224,995 | September 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Gennext Technologies Ltd in April, 2023 for $350,004.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM150353-01 | Phase I | 350,004 | April 1, 2023 |
